Institutional investors purchased a net $4.4 million shares of AEGR during the quarter ended June 2016, and now own 89.09% of the total float, a percentage that is typical for companies in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
Top 10 Owners of Aegerion Pharmaceuticals Inc
Total value ($)
Shares bought / sold
Top 10 Mutual Funds Holding Aegerion Pharmaceuticals Inc